These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 722711)

  • 21. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
    Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
    J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further studies on 6-alkylandrost-4-ene-3,17-diones as aromatase inhibitors: elongation of the 6-alkyl chain.
    Numazawa M; Oshibe M
    Steroids; 1995 Aug; 60(8):506-11. PubMed ID: 8539792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of 4-(substituted thio)-4-androstene-3,17-dione derivatives as potential aromatase inhibitors.
    Abul-Hajj YJ
    J Med Chem; 1986 Apr; 29(4):582-4. PubMed ID: 3959033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aromatase inhibition by 7-substituted steroids in human choriocarcinoma cell culture.
    Brueggemeier RW; Katlic NE; Kenreigh CA; Li PK
    J Steroid Biochem Mol Biol; 1992 Jan; 41(1):85-90. PubMed ID: 1734938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase.
    Numazawa M; Mutsumi A; Hoshi K; Tanaka Y
    Biochem Biophys Res Commun; 1992 Jul; 186(1):32-9. PubMed ID: 1632774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biochemistry of fluorescent aromatase inhibitors.
    Chen HH; Brueggemeier RW
    Steroids; 1990 Mar; 55(3):123-7. PubMed ID: 2333659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships.
    Numazawa M; Yamaguchi S
    J Steroid Biochem Mol Biol; 1998 Oct; 67(1):41-8. PubMed ID: 9780028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active-site-directed inactivation of aromatase from human placental microsomes by brominated androgen derivatives.
    Bellino FL; Gilani SS; Eng SS; Osawa Y; Duax WL
    Biochemistry; 1976 Oct; 15(21):4730-6. PubMed ID: 974087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione.
    Abul-Hajj YJ; Liu XP; Hedge M
    Steroids; 1995 May; 60(5):423-7. PubMed ID: 7570717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biochemical studies of 7-substituted 4,6-androstadiene-3,17-diones as aromatase inhibitors.
    Li PK; Brueggemeier RW
    J Med Chem; 1990 Jan; 33(1):101-5. PubMed ID: 2296006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiol-containing androgens as suicide substrates of aromatase.
    Bednarski PJ; Porubek DJ; Nelson SD
    J Med Chem; 1985 Jun; 28(6):775-9. PubMed ID: 4009599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological characterization of A-ring steroids.
    Johnston JO; Wright CL; Burkhart JP; Peet NP
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):623-31. PubMed ID: 8476773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione.
    Covey DF; Hood WF
    Mol Pharmacol; 1982 Jan; 21(1):173-80. PubMed ID: 7132956
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis and biochemical studies of 7 alpha-substituted androsta-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.
    Ebrahimian S; Chen HH; Brueggemeier RW
    Steroids; 1993 Sep; 58(9):414-22. PubMed ID: 8236327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 6-Alkyl- and 6-arylandrost-4-ene-3,17-diones as aromatase inhibitors. Synthesis and structure-activity relationships.
    Numazawa M; Oshibe M
    J Med Chem; 1994 Apr; 37(9):1312-9. PubMed ID: 8176709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Equine cytochrome P450 aromatase exhibits an estrogen 2-hydroxylase activity in vitro.
    Almadhidi J; Moslemi S; Drosdowsky MA; Séralini GE
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):55-61. PubMed ID: 9009238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen synthesis in human breast tumor and its inhibition by testololactone and bromoandrostenedione.
    Dao TL
    Cancer Res; 1982 Aug; 42(8 Suppl):3338s-3341s. PubMed ID: 7083197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
    Numazawa M; Mutsumi A; Tachibana M
    Biochem Pharmacol; 1996 Oct; 52(8):1253-9. PubMed ID: 8937433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies directed toward a mechanistic evaluation of aromatase inhibition by androst-5-ene-7,17-dione. Time-dependent inactivation by the 19-nor and 5 beta, 6 beta-epoxy derivatives.
    Numazawa M; Tachibana M
    Steroids; 1997 Jul; 62(7):516-22. PubMed ID: 9253790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of estrogen synthesis in human breast tumors by testololactone and bromoandrostenedione.
    Budnick RM; Dao TL
    Steroids; 1980 May; 35(5):533-41. PubMed ID: 7394858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.